Customized research for PBYI vs. SYMQY!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for PBYI vs. SYMQY.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Puma Biotechnology, Inc. vs. SymBio Pharmaceuticals Limited

Industry Match! Industry of Both PBYI and SYMQY:

Health Care/Life Sciences

PBYI
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 483.336M


P/E: N/A

P/S: 1.93

Q P/B: 28.13

Y Rev: 250.99M

Q Rev: 56.35M

Beta: 1.78

PBYI Share Stats

Outstanding Shares

38.61M

Float Shares

33.65M

Percent of Float Short

23.24%

PBYI Insider Stats

Percent Outstanding Insider Ownership

11.81%

Percent Outstanding Institution Ownership

98.79%

PBYI Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

PBYI in Pulse Portal

Stream of Posts

PBYI Symbol Page

Share PBYI Insights

Express Sentiment

'Buy' or 'Sell' PBYI

PBYI Profile

CEO

Mr. Alan H. Auerbach

Exchange

Nasdaq

Employees

272.00

About

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial...

PBYI Financials

Annual Financials

Income Statement

Revenue

250.99M

Net Income

(113.58M)

Cash Flow Statement

Change in Cash / Investments

26.72M

Balance Sheet

Cash / Investments

165.42M

Short Term Debt

None

Long Term Debt

151.89M

Total Current Assets

203M

Total Current Liabilities

67.12M

Total Assets

259.12M

Total Liabilities

224.82M

Stockholder Equity

34.31M

Quarterly Financials

Income Statement

Q Revenue

56.35M

Q Net Income

(16.89M)

Cash Flow Statement

Q Change in Cash / Investments

31.74M

Balance Sheet

Q Cash / Investments

110.44M

Q Short Term Debt

2.52M

Q Long Term Debt

94.19M

Q Total Current Assets

151.06M

Q Total Current Liabilities

88.34M

Q Total Assets

232.04M

Q Total Liabilities

214.86M

Q Stockholder Equity

17.18M

PBYI Charts

10-Year Chart

PBYI 10-Year Chart

5-Year Chart

PBYI 5-Year Chart

1-Year Chart

PBYI 1-Year Chart

6-Month Chart

PBYI 6-Month Chart

3-Month Chart

PBYI 3-Month Chart

1-Month Chart

PBYI 1-Month Chart

1-Day Chart

PBYI 1-Day Chart

SYMQY
Data Last Updated: N/A

↻  Update Column 2 to Most Recent

Key Statistics

Cap: N/A


P/E: N/A

P/S: N/A

Q P/B: N/A

Y Rev: 3.84B

Q Rev: 803.17M

Beta: N/A

SYMQY Share Stats

Outstanding Shares

41.91M

Float Shares

N/A

Percent of Float Short

N/A

SYMQY Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

0%

SYMQY Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

SYMQY in Pulse Portal

Stream of Posts

SYMQY Symbol Page

Share SYMQY Insights

Express Sentiment

'Buy' or 'Sell' SYMQY

SYMQY Profile

CEO

Mr. Fuminori Yoshida

Exchange

OTC

Employees

90.00

About

SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is...

SYMQY Financials

Annual Financials

Income Statement

Revenue

3.84B

Net Income

(2.75B)

Cash Flow Statement

Change in Cash / Investments

1.87B

Balance Sheet

Cash / Investments

4.82B

Short Term Debt

None

Long Term Debt

None

Total Current Assets

6.04B

Total Current Liabilities

1.34B

Total Assets

6.24B

Total Liabilities

1.34B

Stockholder Equity

4.9B

Quarterly Financials

Income Statement

Q Revenue

803.17M

Q Net Income

(811.69M)

Cash Flow Statement

Q Change in Cash / Investments

-

Balance Sheet

Q Cash / Investments

4.82B

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

6.04B

Q Total Current Liabilities

1.34B

Q Total Assets

6.24B

Q Total Liabilities

1.34B

Q Stockholder Equity

4.9B

SYMQY Charts

10-Year Chart

SYMQY 10-Year Chart

5-Year Chart

SYMQY 5-Year Chart

1-Year Chart

SYMQY 1-Year Chart

6-Month Chart

SYMQY 6-Month Chart

3-Month Chart

SYMQY 3-Month Chart

1-Month Chart

SYMQY 1-Month Chart

1-Day Chart

SYMQY 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon